Predict your next investment

Corporation
HEALTHCARE | Dental Products & Services
biohorizons.com

See what CB Insights has to offer

Total Raised

$52.5M

Investors Count

6

Deal Terms

2

BioHorizons Funding, BioHorizons Valuation & BioHorizons Revenue

7 Fundings

BioHorizons's latest funding round was a Recap for $145M on December 31, 2013.

BioHorizons's latest post-money valuation is from December 2013.

Sign up for a free trial to see BioHorizons's valuations in December 2013 and more.

BioHorizons's 2012 revenue was $115M. BioHorizons's most recent revenue is from 2012.

Sign up for a free trial to see revenue data from 2012 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/31/2013

Recap

$145M

$99M

$0.00B

((9.99x))

FY 1234

2

11/26/2013

Corporate Majority

$115M

FY 2012

10

12/19/2012

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

7/29/2011

Debt

$99M

$0.00B

((9.99x))

FY 1234

0

2/25/2008

Merger

0

Date

12/31/2013

11/26/2013

12/19/2012

7/29/2011

2/25/2008

Round

Recap

Corporate Majority

Unattributed

Debt

Merger

Amount

$145M

$99M

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$115M

FY 2012

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

2

10

10

0

0

BioHorizons Deal Terms

2 Deal Terms

BioHorizons's deal structure is available for 2 funding rounds, including their Recap from December 31, 2013.

Round

Recap

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Recap

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

BioHorizons Investors

6 Investors

BioHorizons has 6 investors. Henry Schein invested in BioHorizons's Corporate Majority funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/26/2013

12/31/2013

2
Recap, Corporate Majority (2013)

Corporation

New York

00/00/0000

00/00/0000

Piper Sandler

Subscribe to see more

Investment Bank

Minnesota

00/00/0000

00/00/0000

Deerfield Management

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

DTI Dental Technologies

Subscribe to see more

Corporation

Texas

00/00/0000

00/00/0000

HealthpointCapital

Subscribe to see more

Private Equity

New York

First funding

11/26/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

12/31/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Piper Sandler

Deerfield Management

DTI Dental Technologies

HealthpointCapital

Rounds

2
Recap, Corporate Majority (2013)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Investment Bank

Venture Capital

Corporation

Private Equity

Location

New York

Minnesota

New York

Texas

New York

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.